Endovascular  	Endovascular  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
of  	of  	 IN	I-NP
intracranial  	intracranial  	 NNS	I-NP
stenosis  	stenosis  	 VBP	O
The  	The  	 DT	O
Gateway  	Gateway  	 JJ	B-NP
balloon-Wingspan  	balloon-Wingspan  	 JJ	I-NP
stent  	stent  	 JJ	I-NP
system  	system  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
first 	first 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
currently  	currently  	 RB	O
the  	the  	 DT	O
only  	only  	 JJ	O
on-label  	on-label  	 JJ	B-NP
device  	device  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
symptomatic  	symptomatic  	 JJ	B-NP
intracranial  	intracranial  	 JJ	I-NP
stenosis  	stenosis  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States 	States 	 NNPS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
initial  	initial  	 JJ	O
single-arm  	single-arm  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
investigators  	investigators  	 NNS	B-NP
have  	have  	 VBP	O
indicated  	indicated  	 VBN	O
that  	that  	 IN	O
this  	this  	 DT	O
system  	system  	 NN	O
can  	can  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
symptomatic  	symptomatic  	 JJ	B-NP
intracranial  	intracranial  	 JJ	I-NP
atherosclerotic  	atherosclerotic  	 JJ	I-NP
disease  	disease  	 NN	I-NP
with  	with  	 IN	O
high  	high  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
technical  	technical  	 JJ	B-NP
success  	success  	 NN	I-NP
and  	and  	 CC	O
acceptable  	acceptable  	 JJ	O
periprocedural  	periprocedural  	 JJ	B-NP
complication  	complication  	 NN	I-NP
rates 	rates 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
comparable  	comparable  	 JJ	O
with 	with 	 IN	O
,  	,  	 ,	O
or  	or  	 CC	O
better  	better  	 JJR	O
than 	than 	 IN	O
,  	,  	 ,	O
those  	those  	 DT	O
reported  	reported  	 VBN	O
for  	for  	 IN	O
other  	other  	 JJ	O
endovascular  	endovascular  	 JJ	B-NP
techniques 	techniques 	 NNS	I-NP
.  	.  	 .	O
Intermediate-  	Intermediate-  	 NNP	O
and  	and  	 CC	O
long-term  	long-term  	 JJ	O
follow-up  	follow-up  	 JJ	B-NP
data  	data  	 NNS	I-NP
for  	for  	 IN	O
patients  	patients  	 NNS	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
Wingspan  	Wingspan  	 JJ	B-NP
device  	device  	 NN	I-NP
remain  	remain  	 VBP	O
sparse 	sparse 	 VBN	O
.  	.  	 .	O
We  	We  	 PRP	O
critically  	critically  	 RB	O
review  	review  	 VB	O
the  	the  	 DT	O
existing  	existing  	 JJ	O
data 	data 	 NNS	O
,  	,  	 ,	O
which  	which  	 WDT	O
characterize  	characterize  	 VBP	O
the  	the  	 DT	O
risk  	risk  	 NN	B-NP
profile  	profile  	 NN	I-NP
and  	and  	 CC	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
endovascular  	endovascular  	 JJ	B-NP
interventions  	interventions  	 NNS	I-NP
for  	for  	 IN	I-NP
intracranial  	intracranial  	 JJ	I-NP
atherosclerotic  	atherosclerotic  	 JJ	I-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
available  	available  	 JJ	O
clinical  	clinical  	 JJ	B-NP
evidence  	evidence  	 NN	I-NP
that  	that  	 WDT	O
could  	could  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
select  	select  	 VB	O
appropriate  	appropriate  	 JJ	O
patients  	patients  	 NNS	O
for  	for  	 IN	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
